...
首页> 外文期刊>Clinical and Experimental Immunology: An Official Journal of the British Society for Immunology >Decreased T-bet expression and changes in chemokine levels in adults with asthma.
【24h】

Decreased T-bet expression and changes in chemokine levels in adults with asthma.

机译:成人哮喘患者的T-bet表达降低和趋化因子水平变化。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Summary T-bet is a novel transcription factor regulating lineage commitment of T helper (Th) lymphocytes to a predominant Th1 phenotype. Previous studies on T-bet and asthma focused mainly on bronchial biopsy specimens. This study assessed the relationship between T-bet expression and levels of selected chemokines in the peripheral blood of asthmatics. Blood was collected from 24 steroid-naive asthmatics, 39 asthmatics on inhaled corticosteroid and 32 age- and sex-matched controls for assay of T-bet expression, specific IgE and chemokines (interferon-gamma inducible protein-10 (IP-10/CXCL10), monokines induced by interferon-gamma (MIG/CXCL9), monocyte chemotactic protein-1 (MCP-1/CCL2), regulated upon activation normal T cell expressed and secreted (RANTES/CCL5) and interleukin-8 (IL-8/CXCL8) levels. T-bet mRNA expression was assessed by real-time quantitative reverse transcription-polymerase chain reaction (RT-PCR). Chemokine levels were assessed by immunofluorescence flow cytometry. The mean (s.d.) age and forced expiratory volume in 1 s (FEV(1))% predicted of the asthmatics were 43.6 (14.6) years and 85.9 (20.0)%, respectively. The median (IQR) T-bet expression after normalization with beta-actin was suppressed in asthmatics versus controls [asthmatics 0.71 (0.59) versus controls 1.07 (1.14), P = 0.03].The median (IQR) of plasma RANTES was elevated, whereas IP-10 was suppressed in asthmatics versus controls (RANTES: 13 658.0 (13673.3) versus 6299.5 (19 407.8) pg/ml, P = 0.03; IP-10: 1047.6 (589.8) versus 1306.4 (759.9) pg/ml, P = 0.001). There was a weak and negative correlation between T-bet expression and RANTES level in the asthmatics (r = -0.29, P = 0.032). T-bet could be measured in peripheral blood and its expression was suppressed in asthmatics. This is in keeping with asthma being a predominantly Th2 disease and T-bet probably plays a role in the pathogenesis of asthma. Further studies are needed to explore the potential application of peripheral blood monitoring of T-bet.
机译:总结T-bet是一种新型的转录因子,可调节T辅助(Th)淋巴细胞向主要Th1表型的谱系承诺。先前有关T-bet和哮喘的研究主要集中在支气管活检标本上。这项研究评估了哮喘患者外周血T-bet表达与选定趋化因子水平之间的关系。从24名未使用过类固醇的哮喘患者,39名吸入皮质类固醇的哮喘患者以及32个年龄和性别匹配的对照组中采集血液,以测定T-bet表达,特异性IgE和趋化因子(干扰素-γ诱导型蛋白10(IP-10 / CXCL10 ),干扰素-γ(MIG / CXCL9),单核细胞趋化蛋白1(MCP-1 / CCL2)诱导的单核因子,在激活正常T细胞表达和分泌(RANTES / CCL5)和白介素8(IL-8 /通过实时定量逆转录聚合酶链反应(RT-PCR)评估T-bet mRNA的表达;通过免疫荧光流式细胞术评估趋化因子的水平;平均年龄(sd)和强迫呼气量在1 s内(FEV(1))%的哮喘患者预测分别为43.6(14.6)岁和85.9(20.0)%。用β-肌动蛋白正常化后,哮喘患者与对照组相比,中位(IQR)T-bet表达受到抑制[哮喘患者0.71 (0.59)与对照组的1.07(1.14),P = 0.03]。血浆R的中位数(IQR)与对照组相比,ANTES升高,而哮喘患者的IP-10受到抑制(RANTES:13 658.0(13673.3)与6299.5(19 407.8)pg / ml,P = 0.03; IP-10:1047.6(589.8)和1306.4(759.9)pg / ml,P = 0.001)。哮喘患者的T-bet表达与RANTES水平之间呈弱而负相关(r = -0.29,P = 0.032)。 T-bet可以在外周血中测定,其表达在哮喘患者中被抑制。这与哮喘主要是Th2疾病保持一致,T-bet可能在哮喘的发病机理中起作用。需要进一步的研究以探索T-bet外周血监测的潜在应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号